Cabinet approves MoU between India and Indonesia in the field of pharmaceutical products

The Union Cabinet chaired by Prime Minister Narendra Modi has given its ex-post facto approval for the memorandum of understanding (MoU) between the Central Drugs Standard Control Organization (CDSCO), India and National Agency for Drug and Food Control (BPOM), Indonesia on cooperation in the field of pharmaceutical products, pharmaceutical substances, biological products, and cosmetics regulatory functions. The MoU was on signed on May 29, 2018 in Jakarta.

The MoU is expected to forge better understanding about each other’s regulatory requirements and would be beneficial to both the countries. It could also facilitate India’s export of pharmaceutical products. It will also establish a framework for fruitful cooperation and exchange of information between the two countries in matters relating to pharmaceutical products regulation on the basis of equality, reciprocity, and mutual benefit. Further, it will facilitate better understanding between the regulatory authorities of the two countries.